NEW DELHI: The incidence of cancer in India has gone up by 26%, from 84.8 per 1 lakh population in 1990 to 107.2 in 2023, according to a new study. Published in The Lancet, it shows deaths due to cancer increased by 21% during this period, despite advances in treatment. In comparison, both incidence and mortality have declined significantly in US and China over the 33-year period. The reason behind this is strong tobacco control, universal vaccination and organised screening in these two countries, Dr Abhishek Shankar, radiation-oncologist at AIIMS Delhi, said. India, he added, continues to fare poorly on both counts because of persisting risk factors such as high use of tobacco, obesity and infections, coupled with limited access to early detection.Study links 4.3m cancer deaths in 2023 to modifiable risk factors Evidence-based strategies like HPV and Hepatitis-B vaccination, mammography, lung cancer screening with low-dose CT, and colonoscopy screening, and timely treatment remain uneven or inadequate. For India to reverse its trajectory, we must urgently strengthen risk prevention strategies, expand evidence-based screening programmes and integrate cancer care into its universal health coverage agenda,” Shankar said. The study’s lead author Dr Lisa Force from the Institute for Health Metrics and Evaluation (IHME), University of Washington, said, “Cancer remains an important contributor to disease burden globally and our study highlights how it is anticipated to grow substantially over the coming decades, with disproportionate growth in countries with limited resources.” She added that despite the clear need for action, cancer control policies and implementation remain under-prioritised in global health, and there is insufficient funding to address this challenge in many settings. The study shows cancer incidence has declined by 19% and 20% in China and the US, respectively, between 1990 and 2023, while their mortality rates attributable to cancer has also seen a robust decline – 43% decline in mortality due to cancer in China and 33% in the US. The study estimates that 42% (4.3 million) of the estimated 10.4 million cancer deaths in 2023 were attributable to 44 potentially modifiable risk factors – presenting an opportunity for action. “Behavioural risk factors contributed to the most cancer deaths across all country income levels in 2023, especially tobacco use which contributed to 21% of cancer deaths globally. Tobacco was the leading risk factor in all country income levels except low-income countries, where the leading risk factor was unsafe sex (linked to 12.5% of all cancer deaths),” the study said. A parliamentary committee report tabled in 2023 suggested raising taxes on tobacco products in India to make them less affordable. “Committee recommends the ministry (health) to pursue with the department of revenue to expedite the decision on raising taxes on tobacco products,” it said. It also stressed upon the need to link the Population-Based Cancer Registry to Ayushman Bharat Digital Mission to get real time data on cancer patients. The mission is a key health initiative by the govt which aims at providing digital health IDs for all Indian citizens to help hospitals, insurance firms, and citizens access health records electronically when required. Most cancer cases in India are detected in late stages leading to poor prognosis. The parliamentary committee suggested that the issue of screening for cancer should be taken up at ‘Jan Aandolan Pace’, a mass movement to fight against cancer by timely screening. “A day in a month may be fixed for cancer screening on the lines of reproductive and child health,” the parliamentary committee suggested. Go to Source
